Navigation Links
Building Stronger Relationships with Key Opinion Leaders Ignites Need for Medical Science Liaisons
Date:8/7/2013

CHAPEL HILL, N.C., Aug. 7, 2013 /PRNewswire/ -- As regulatory and commercial pressures increase on pharmaceutical organizations, competition for the support of physicians and Key Opinion Leaders (KOLs) is simultaneously intensifying. In order to build stronger relationships with these physician groups, biopharma organizations heavily rely on Medical Science Liaisons (MSL) as a part of their Medical Affairs functions.

To help organizations better understand how MSLs can provide critical windows of insight into the market, Best Practices, LLC conducted a comprehensive research study. The benchmarking report, "Roles, Resourcing, and Management of Medical Science Liaisons," further explores the many diverse roles that MSLs play in developing critical relationships that drive success in the pharmaceutical sector.

The report covers various topical areas, including the frequency of interactions between KOLs and MSLs, as well as the perceived value of MSL responsibilities with KOLs. Eighty-nine percent of respondents saw identifying, developing and maintaining strong relationships with KOLs as a "very valuable" activity performed by MSLs. Other highly valued activities included increased scientific interaction and congress support.

Key study objectives included:

  • Benchmarking Pre and Post-Launch Service Activities
  • Identify Drivers of Group Size & Focus
  • Gain Insight into Structuring & Aligning Medical with Sales Organizations
  • Identify Optimal Call Frequencies and Service Levels with Thought Leaders
  • Identify Relationship Management Standards of Excellence
  • Value Associated with MSL
  • Budget Allocation to MSLs
  • '/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Specialty Operations Solutions joins The WorkingBuildings Companies
2. Cannabis Science Appoints Clinical Development Expert, Dr. Dorothy Bray, as Chief Executive Officer (CEO) and Director, Focusing on CS-TATI-1 and Building Companys Drug Development Pipeline
3. Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas
4. US Vitamin Injections Posts New Article about the Science of Muscle Building
5. US Vitamin Injections Post New Article about Natural Bodybuilding
6. High-Impact Recalls -- Building a Process to Avoid Disaster
7. Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named Ernst & Young U.S. 2012 Family Business Award of Excellence winner
8. The University of Munich Hospital and Clinics Selects Brainlab Buzz Digital O.R. to Equip All 32 Operating Rooms in New Grobhadern Surgical Building
9. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
10. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
11. GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
(Date:6/29/2015)... ... , ... USA Today reported on June 18th the overdose death ... impact the rest of the nation’s growing overdose death rates in 26 other states ... followed to stop the increasing overdose trend from continuing: , , ...
(Date:6/29/2015)... ... , ... OR Manager announced Monday the launch of an enhanced http://www.ormanager.com ... redesigned logo and weekly eLetter. The website contains the same informational articles, products, and ... navigate. , In addition to a refreshed look, http://www.ormanager.com now provides ...
(Date:6/29/2015)... ... June 29, 2015 , ... New research ... fewer than 10 percent of U.S. state and local governments have implemented Next ... implementation deadline for NG9-1-1. , “Mobile phones have surpassed land lines as ...
(Date:6/29/2015)... ... 2015 , ... The Food Safety and Technology Research Centre ... Polytechnic University (PolyU) has developed a new method for rapid authentication of edible ... long-term issue in food safety, and becomes particularly important with the emergence and ...
(Date:6/29/2015)... ... , ... FACE is proud to be one of the first in the ... chin and redefining of the jawline. Excess fat under the chin and around ... the person distress and poor self-image. , Kybella was produced by KYTHRA Biopharmaceutical and ...
Breaking Medicine News(10 mins):Health News:Overdose Death Rates Decreased in Florida as of 2015 2Health News:Overdose Death Rates Decreased in Florida as of 2015 3Health News:OR Manager Launches New Website 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:FACE Detroit Skin and Wellness Clinic Introduces Newly FDA Approved Kybella for the elimination of the Double Chin. 2
... DHR ) commented today on the performance outlook of ... Culp, Jr. communicated the company expects 2009 earnings per share to ... , Mr. Culp stated, "We have taken significant ... a difficult year ahead. However, despite the current economic backdrop, we ...
... Study says high-altitude cerebral edema is a common problem ... Most deaths on Mount Everest occur during descents from ... meters, and high-altitude cerebral edema appears to be associated ... conclusion of researchers who analyzed the reported 212 deaths ...
... ROCK, Ark., Dec. 11 Travel Nurse across ... for healthcare staffing,services from The Joint Commission. , ... across America, a national supplemental healthcare staffing,firm, recently ... with,national standards addressing how staffing firms determine the ...
... eligible voters cast ballots in statewide election while caregivers file ... LOS ANGELES, Dec. 11 In a statewide vote of ... ballots are still being counted but the result is clear: ... union officials, and lawmakers and healthcare advocates are joining them ...
... of Tourette Syndrome , , ... last Sunday night,s Hallmark Hall of Fame presentation of "Front ... story of a young man,s struggles with and triumph over ... The national Tourette Syndrome Association, Inc. (TSA) is privileged to ...
... used to prep for colonoscopy, may harm the kidneys, ... THURSDAY, Dec. 11 (HealthDay News) -- Two prescription drugs ... cause kidney damage, the U.S. Food and Drug Administration ... require a black-box warning on the oral sodium phosphate ...
Cached Medicine News:Health News:Danaher CEO Comments on Outlook 2Health News:Most Mt. Everest Deaths Occur Near Summit During Descent 2Health News:Travel Nurse Across America Awarded Certification From The Joint Commission 2Health News:Boycott Prevails in Sham SEIU Vote; Lawmakers and Advocates Join Healthcare Workers in Opposing Forced Union Merger 2Health News:Hallmark Hall of Fame Collaboration with Patient Organization Equals Extraordinary Success 2Health News:FDA Puts Black-Box Warning on Bowel-Cleansing Drugs 2Health News:FDA Puts Black-Box Warning on Bowel-Cleansing Drugs 3
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: